Intercure (XTAE:INCR) Days Inventory : 182.99 (As of Jun. 2023)

View and export this data going back to 2007. Start your Free Trial

What is Intercure Days Inventory?

Days Inventory is also known as Days Sales of Inventory (DSI). Intercure's Average Total Inventories for the three months ended in Jun. 2023 was ₪140.0 Mil. Intercure's Cost of Goods Sold for the three months ended in Jun. 2023 was ₪69.8 Mil. Hence, Intercure's Days Inventory for the three months ended in Jun. 2023 was 182.99.

The historical rank and industry rank for Intercure's Days Inventory or its related term are showing as below:

XTAE:INCR' s Days Inventory Range Over the Past 10 Years
Min: 127.89 Med: 154.53 Max: 310.64
Current: 179.27

During the past 13 years, Intercure's highest Days Inventory was 310.64. The lowest was 127.89. And the median was 154.53.

XTAE:INCR's Days Inventory is ranked worse than
58.38% of 973 companies
in the Drug Manufacturers industry
Industry Median: 157.9 vs XTAE:INCR: 179.27

Intercure's Days Inventory increased from Jun. 2022 (164.91) to Jun. 2023 (182.99). It might indicate that Intercure's sales slowed down.

Warning Sign:

If a company builds up inventory, it may mean it is having difficulties selling its goods.

Inventory Turnover measures how fast the company turns over its inventory within a year. Intercure's Inventory Turnover for the three months ended in Jun. 2023 was 0.50.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Intercure's Inventory-to-Revenue for the three months ended in Jun. 2023 was 1.37.

Intercure Days Inventory Historical Data

The historical data trend for Intercure's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Intercure Days Inventory Chart

Intercure Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Days Inventory

Get a 7-Day Free Trial

283.79

154.52

127.89

151.86

Intercure Quarterly Data
	Jun18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
Days Inventory	Get a 7-Day Free Trial															164.91	227.11	149.78	166.97	182.99

Competitive Comparison of Intercure's Days Inventory

For the Drug Manufacturers - Specialty & Generic subindustry, Intercure's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Intercure's Days Inventory Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Intercure's Days Inventory distribution charts can be found below:

* The bar in red indicates where Intercure's Days Inventory falls into.

Intercure Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Intercure's Days Inventory for the fiscal year that ended in Dec. 2022 is calculated as

	Days Inventory (A: Dec. 2022 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (A: Dec. 2021 )	+	Total Inventories (A: Dec. 2022 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2022 )	*	Days in Period
=	( (67.879	+	126.498)	/	2 )	/	233.601	*	365
=	97.1885					/	233.601	*	365
=	151.86

Intercure's Days Inventory for the quarter that ended in Jun. 2023 is calculated as:

	Days Inventory (Q: Jun. 2023 )
=	Average Total Inventories					/	Cost of Goods Sold	*	Days in Period
=	( (Total Inventories (Q: Mar. 2023 )	+	Total Inventories (Q: Jun. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Jun. 2023 )	*	Days in Period
=	( (136.445	+	143.501)	/	2 )	/	69.798	*	365 / 4
=	139.973					/	69.798	*	365 / 4
=	182.99

Intercure (XTAE:INCR) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Intercure's Inventory Turnover for the three months ended in Jun. 2023 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	69.798	/	139.973
	=	0.50

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Intercure's Inventory to Revenue for the three months ended in Jun. 2023 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	139.973	/	102.439
	=	1.37

Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.

Intercure Days Inventory Related Terms

Thank you for viewing the detailed overview of Intercure's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Intercure (XTAE:INCR) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Intercure Ltd (XTAE:INCR) » Definitions » Days Inventory

Comparable Companies

Traded in Other Exchanges

INCR:USA

Address

85 Medinat ha-Yehudim Street, Herzliya, ISR, 4676670

Website

https://www.intercure.co

Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. The products are distributed to hospitals, pharmacies, research, and government organizations.